Adaptimmune Therapeutics
ADAP
#9327
Rank
$66.39 M
Marketcap
$0.26
Share price
-20.31%
Change (1 day)
-81.02%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Cash on Hand

Cash on Hand as of December 2024 : $0.15 Billion USD

According to Adaptimmune Therapeutics's latest financial reports the company has $0.15 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Adaptimmune Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.14 B-28.18%
2022-12-31$0.20 B-44.64%
2021-12-31$0.36 B0.37%
2020-12-31$0.36 B311.22%
2019-12-31$89.54 M-56.35%
2018-12-31$0.20 B-1.5%
2017-12-31$0.20 B14.76%
2016-12-31$0.18 B
2015-06-30$0.28 B454.55%
2014-06-30$51.27 M20592.35%
2013-06-30$0.24 M-91.8%
2012-06-30$3.02 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.92 B 508.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$40.29 M-73.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.36 B 142.42%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$1.11 B 633.01%๐Ÿ‡บ๐Ÿ‡ธ USA